Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
09 08 2022
Historique:
received: 03 01 2022
accepted: 15 04 2022
pubmed: 3 5 2022
medline: 5 8 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Mast cell accumulation is a hallmark of a number of diseases, including allergic asthma and systemic mastocytosis. Immunoglobulin E-mediated crosslinking of the FcεRI receptors causes mast cell activation and contributes to disease pathogenesis. The mast cell lineage is one of the least studied among the hematopoietic cell lineages, and controversies remain about whether FcεRI expression appears during the mast cell progenitor stage or during terminal mast cell maturation. Here, we used single-cell transcriptomics analysis to reveal a temporal association between the appearance of FcεRI and the mast cell gene signature in CD34+ hematopoietic progenitors in adult peripheral blood. In agreement with these data, the FcεRI+ hematopoietic progenitors formed morphologically, phenotypically, and functionally mature mast cells in long-term culture assays. Single-cell transcriptomics analysis further revealed the expression patterns of prospective cytokine receptors regulating development of mast cell progenitors. Culture assays showed that interleukin-3 (IL-3) and IL-5 promoted disparate effects on progenitor cell proliferation and survival, respectively, whereas IL-33 caused robust FcεRI downregulation. Taken together, we showed that FcεRI expression appears at the progenitor stage of mast cell differentiation in peripheral blood. We also showed that external stimuli regulate FcεRI expression of mast cell progenitors, providing a possible explanation for the variable FcεRI expression levels during mast cell development.

Identifiants

pubmed: 35500226
pii: 485139
doi: 10.1182/bloodadvances.2022006969
pmc: PMC9636317
doi:

Substances chimiques

Receptors, IgE 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4439-4449

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Methods Cell Biol. 2011;103:333-59
pubmed: 21722810
Scand J Immunol. 1994 May;39(5):489-98
pubmed: 8191224
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Mol Immunol. 2015 May;65(1):68-76
pubmed: 25645506
Nat Cell Biol. 2017 Apr;19(4):271-281
pubmed: 28319093
J Allergy Clin Immunol. 2011 Apr;127(4):905-12.e1-7
pubmed: 21388666
Int Immunol. 1996 Sep;8(9):1367-73
pubmed: 8921414
Blood. 1994 Oct 15;84(8):2489-96
pubmed: 7522630
Nature. 2018 Mar 1;555(7694):54-60
pubmed: 29466336
Front Immunol. 2019 Jun 19;10:1361
pubmed: 31275312
J Immunol Methods. 2021 Aug;495:113061
pubmed: 33933470
Immunity. 2019 Apr 16;50(4):796-811
pubmed: 30995500
J Immunol. 1999 May 1;162(9):5455-65
pubmed: 10228025
Blood. 2014 Apr 24;123(17):e58-67
pubmed: 24671954
Mol Syst Biol. 2018 Mar 15;14(3):e8041
pubmed: 29545397
Exp Dermatol. 2006 Jul;15(7):530-7
pubmed: 16761962
J Exp Med. 1999 Jul 19;190(2):267-80
pubmed: 10432289
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
Science. 1989 Apr 21;244(4902):334-7
pubmed: 2523561
Nat Commun. 2019 Jun 3;10(1):2395
pubmed: 31160568
J Allergy Clin Immunol. 2016 Jun;137(6):1863-1871.e6
pubmed: 26774658
Immunology. 1993 Jun;79(2):325-30
pubmed: 7688344
Allergy. 2022 Jan;77(1):83-99
pubmed: 33955017
Leukemia. 2016 Sep;30(9):1953-6
pubmed: 27118407
Blood. 1999 Oct 1;94(7):2333-42
pubmed: 10498605
Immunology. 1996 Jun;88(2):308-14
pubmed: 8690466
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Blood. 1995 Nov 15;86(10):3705-14
pubmed: 7579337
J Leukoc Biol. 2008 Feb;83(2):334-43
pubmed: 17998301
Blood. 2016 Jan 28;127(4):383-91
pubmed: 26626992
J Biol Chem. 1992 Jun 25;267(18):12782-7
pubmed: 1535625
Theranostics. 2020 Aug 29;10(23):10743-10768
pubmed: 32929378
Blood. 2017 Oct 19;130(16):1785-1794
pubmed: 28790106
Leuk Res. 1988;12(4):345-55
pubmed: 3131594

Auteurs

Chenyan Wu (C)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Daryl Boey (D)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Oscar Bril (O)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Jennine Grootens (J)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

M S Vijayabaskar (MS)

Department of Haematology, Jeffrey Cheah Biomedical Centre, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Chiara Sorini (C)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Maria Ekoff (M)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Nicola K Wilson (NK)

Department of Haematology, Jeffrey Cheah Biomedical Centre, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Johanna S Ungerstedt (JS)

Hematology and Regenerative Medicine, HERM, Department of Medicine Huddinge, Karolinska Institutet and ME Hematology, Karolinska University Hospital, Stockholm, Sweden; and.

Gunnar Nilsson (G)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Joakim S Dahlin (JS)

Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH